The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs.

Park, Heung Woo; Kim, Sang Heon; Chang, Yoon Seok; Kim, Sang Hoon; Jee, Young Koo; Lee, Ai Young; Jang, In Jin; Park, Hae Sim; Min, Kyung Up

Park, Heung Woo; Kim, Sang Heon; Chang, Yoon Seok; Kim, Sang Hoon; Jee, Young Koo; Lee, Ai Young; Jang, In Jin; Park, Hae Sim; Min, Kyung Up.

Afiliación

Park HW; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Kim SH; Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, Korea. guinea71@snu.ac.kr.
Chang YS; Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
Kim SH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Jee YK; Department of Internal Medicine, Eulji University School of Medicine, Daejeon, Korea.
Lee AY; Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea.
Jang IJ; Department of Dermatology, Dongguk University Ilsan Hospital, Goyang, Korea.
Park HS; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine, Seoul, Korea.
Min KU; Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.

Allergy Asthma Immunol Res ; 10(5): 555-561, 2018 Sep.

Article en En | MEDLINE | ID: mdl-30088374

Palabras clave

Drug; Fas signaling pathway; Stevens-Johnson syndrome; genome-wide association study; toxic epidermal necrolysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Allergy Asthma Immunol Res Año: 2018 Tipo del documento: Article Pais de publicación:

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google